[Antiemetic efficacy of betamethasone versus betamethasone combined with metoclopramide in cisplatin-treated cancer patients]

Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 1):807-10.
[Article in Japanese]

Abstract

This study was designed to compare the antiemetic effect of betamethasone alone with that of betamethasone combined with metoclopramide. Forty-seven patients on chemotherapeutic regimens including cisplatin were entered into this study. Betamethasone was given in 4 doses of 20 mg/body at 30 minutes before and at 2.5 and 8 hours after cisplatin. Metoclopramide was given in 4 doses of 1mg/kg on the same schedule. Within 24 hours after the administration of cisplatin, no vomiting was observed in 42.9% of the patients treated with betamethasone alone and in 76.9% with betamethasone and metoclopramide. Betamethasone combined with metoclopramide was superior to betamethasone alone for the antiemetic effect in cisplatin-treated patients.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Antiemetics / administration & dosage*
  • Betamethasone / administration & dosage*
  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects*
  • Drug Evaluation
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Metoclopramide / administration & dosage*
  • Middle Aged
  • Neoplasms / drug therapy*
  • Vomiting / chemically induced
  • Vomiting / prevention & control*

Substances

  • Antiemetics
  • Betamethasone
  • Metoclopramide
  • Cisplatin